T Cell Responses Induced by Attenuated Flavivirus Vaccination Are Specific and Show Limited Cross-Reactivity with Other Flavivirus Species

J Virol. 2020 May 4;94(10):e00089-20. doi: 10.1128/JVI.00089-20. Print 2020 May 4.

Abstract

Members of the flavivirus genus share a high level of sequence similarity and often circulate in the same geographical regions. However, whether T cells induced by one viral species cross-react with other related flaviviruses has not been globally addressed. In this study, we tested pools of epitopes derived from dengue (DENV), Zika (ZIKV), Japanese encephalitis (JEV), West Nile (WNV), and yellow fever (YFV) viruses by intracellular cytokine staining (ICS) using peripheral blood mononuclear cells (PBMCs) of individuals naturally exposed to DENV or immunized with DENV (TV005) or YF17D vaccine. CD8 T cell responses recognized epitopes from multiple flaviviruses; however, the magnitude of cross-reactive responses was consistently severalfold lower than those to the autologous epitope pools and was associated with lower expression of activation markers such as CD40L, CD69, and CD137. Next, we characterized the antigen sensitivity of short-term T cell lines (TCL) representing 29 different individual epitope/donor combinations. TCL derived from DENV monovalent vaccinees induced CD8 and CD4 T cells that cross-reacted within the DENV serocomplex but were consistently associated with >100-fold-lower antigen sensitivity for most other flaviviruses, with no cross-recognition of YFV-derived peptides. CD8 and CD4 TCL from YF17D vaccinees were associated with very limited cross-reactivity with any other flaviviruses and in five out of eight cases >1,000-fold-lower antigen sensitivity. Overall, our data suggest limited cross-reactivity for both CD4 and CD8 T cell responses between flaviviruses and have implications for understanding immunity elicited by natural infection and strategies to develop live attenuated vaccines against flaviviral species.IMPORTANCE The envelope (E) protein is the dominant target of neutralizing antibodies for dengue virus (DENV) and yellow fever virus (YFV). Accordingly, several DENV vaccine constructs use the E protein in a live attenuated vaccine format, utilizing a backbone derived from a heterologous flavivirus (such as YF) as a delivery vector. This backbone comprises the nonstructural (NS) and capsid (C) antigens, which are dominant targets of T cell responses. Here, we demonstrate that cross-reactivity at the level of T cell responses among different flaviviruses is very limited, despite high levels of sequence homology. Thus, the use of heterologous flavivirus species as a live attenuated vaccine vector is not likely to generate optimal T cell responses and might thus impair vaccine performance.

Keywords: DENV; T cells; YFV; flaviviruses; vaccines.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, N.I.H., Intramural

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Neutralizing / immunology
  • Antibodies, Viral / immunology
  • CD4-Positive T-Lymphocytes
  • CD8-Positive T-Lymphocytes / immunology
  • Cross Reactions / immunology*
  • Dengue / immunology
  • Dengue / prevention & control
  • Dengue Vaccines / immunology
  • Dengue Virus / immunology
  • Encephalitis, Japanese / immunology
  • Encephalitis, Japanese / prevention & control
  • Epitopes, T-Lymphocyte / genetics
  • Female
  • Flavivirus / immunology*
  • Flavivirus Infections / immunology*
  • Flavivirus Infections / prevention & control
  • Humans
  • Leukocytes, Mononuclear / immunology
  • Male
  • Middle Aged
  • Sequence Homology
  • Vaccination*
  • Vaccines, Attenuated / immunology*
  • Viral Vaccines / immunology*
  • West Nile Fever / immunology
  • West Nile Fever / prevention & control
  • Yellow Fever / immunology
  • Yellow Fever / prevention & control
  • Yellow Fever Vaccine
  • Yellow fever virus / immunology
  • Young Adult
  • Zika Virus / immunology
  • Zika Virus Infection / immunology
  • Zika Virus Infection / prevention & control

Substances

  • Antibodies, Neutralizing
  • Antibodies, Viral
  • Dengue Vaccines
  • Epitopes, T-Lymphocyte
  • Vaccines, Attenuated
  • Viral Vaccines
  • Yellow Fever Vaccine